Genetic Technologies Acquires AffinityDNA Direct-to-Consumer Business

Genetic Technologies Acquires EasyDNA from BelHealth

July 19, 2021

Biotechnology

Genetic Technologies Limited (GENE/GTG) acquired the direct-to-consumer eCommerce business, brands and distribution rights of General Genetics Corporation trading as EasyDNA from BelHealth Investment Fund LP for US$4.0 million (cash, ADRs and escrow). The deal gives Genetic Technologies an established DTC genomics platform and distribution in ~40 countries (70+ websites) to accelerate its health & wellness and serious-disease test commercialisation and global expansion.

Dotmatics Acquires SoftGenetics to Expand Genetic Analysis Capabilities

June 12, 2023

Software

Dotmatics has acquired SoftGenetics, a bioinformatics software company that provides genetic analysis tools for research, clinical, and forensic applications. The acquisition expands Dotmatics' R&D scientific software portfolio by adding SoftGenetics' suite of sequencing and genotyping products while allowing SoftGenetics to operate as a standalone business within Dotmatics.

Eurobio Scientific Acquires GenDx (Genome Diagnostics B.V.)

October 4, 2022

Biotechnology

Paris-based Eurobio Scientific has acquired all outstanding shares of Dutch transplant diagnostics specialist GenDx (Genome Diagnostics B.V.), following a share purchase agreement signed on August 17. The acquisition expands Eurobio's molecular diagnostics portfolio in transplantation and secures the company legacy with proceeds funding a GenDx foundation established by the founders.

Twist Bioscience Acquires iGenomX

June 30, 2021

Biotechnology

Twist Bioscience acquired iGenomX, a developer of high-throughput multiplex NGS library preparation tools, to expand its NGS workflow capabilities and accelerate customer conversion from microarray genotyping to sequencing-based genotyping. The deal consideration was $35 million (combination of cash and Twist stock, plus up to $5 million contingent stock), and Twist expects modest near-term financial impact with incremental revenue from the acquired business in fiscal 2023.

AMP Agency Acquires Genome

May 24, 2022

Marketing & Advertising

AMP Agency, a full-service digital marketing agency and part of Advantage Solutions, has acquired Genome, an award-winning digital innovation and product development company. The acquisition strengthens AMP Agency's technology and product capabilities and supports its strategy to scale technology-enabled innovation and expand internationally; Genome's leadership will join AMP in senior technology roles.

Biotage AB Acquires ATDBio

October 20, 2021

Biotechnology

Swedish life sciences company Biotage AB has acquired UK-based oligonucleotide specialist ATDBio for approximately £45 million in cash and shares. The deal brings ATDBio’s complex DNA/RNA synthesis capabilities and its founders into the Biotage Group to accelerate capability expansion and scale molecular diagnostics, therapeutics and sequencing support services.